Sector footprint
$1.3M in exports
Reported chemicals exports in 2024 across 16 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Explore Congo, Rep. of the's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Chemicals capability
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Sector footprint
Reported chemicals exports in 2024 across 16 qualifying HS6 products.
Global demand
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $39.6B | $4.2K | $15.9B | -23.0% | 7 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $28.8B | $19.2K | $10.9B | +9.5% | 12 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $13.1B | $2.2K | $7.7B | +21.7% | 6 | +0.0% |
| HS 330300Perfumes and toilet waters | $12.6B | $112.0K | $7.3B | +1.1% | 7 | +0.0% |
| HS 282200Cobalt oxides and hydroxides: commercial cobalt oxides | $2.4B | $629.3K | $4.5B | -45.6% | 1 | +2.3% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $11.6B | $8.4K | $4.4B | +3.8% | 5 | +0.0% |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $9.0B | $18.3 | $3.9B | -49.4% | 2 | +0.0% |
| HS 330210Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.8B | $40.9 | $1.2B | -27.4% | 2 | +0.0% |
| HS 294190Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $146.4K | $989.7M | +21.2% | 1 | +0.0% |
| HS 330290Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $209.0K | $803.0M | +15.6% | 1 | +0.0% |
| HS 284440Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $2.4K | $685.2M | +13.3% | 1 | +0.0% |
| HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $397.1M | $192.3K | $433.2M | -6.8% | 1 | +0.1% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $979.8M | $5.6K | $389.2M | -6.9% | 1 | +0.0% |
| HS 381121Lubricating oil additives: containing petroleum oils or oils obtained from bituminous minerals | $692.3M | $314.2 | $362.9M | -3.8% | 1 | +0.0% |
| HS 284410Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $934.1M | $2.7 | $339.7M | -30.7% | 1 | +0.0% |
| HS 350790Enzymes and prepared enzymes: other than rennet and concentrates thereof | $989.3M | $4.4K | $310.4M | -9.9% | 1 | +0.0% |
Best markets
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
CHN
4 products represented in the sector.
$12.3B$18.7B reported buyer importsFRA
10 products represented in the sector.
$8.3B$23.6B reported buyer importsUSA
5 products represented in the sector.
$7.1B$18.3B reported buyer importsNLD
4 products represented in the sector.
$6.9B$15.2B reported buyer importsDEU
5 products represented in the sector.
$6.0B$13.2B reported buyer importsCAN
3 products represented in the sector.
$5.7B$10.4B reported buyer importsGBR
3 products represented in the sector.
$3.3B$5.9B reported buyer importsESP
2 products represented in the sector.
$2.0B$2.8B reported buyer importsITA
3 products represented in the sector.
$1.9B$3.6B reported buyer importsAUT
1 products represented in the sector.
$1.5B$3.7B reported buyer importsIND
2 products represented in the sector.
$1.4B$1.3B reported buyer importsKOR
1 products represented in the sector.
$1.1B$3.8B reported buyer importsGrowth stars
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | +21.7% | $7.7B | 6 |
| HS 294190Antibiotics: n.e.c. in heading no. 2941 | +21.2% | $989.7M | 1 |
| HS 330290Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | +15.6% | $803.0M | 1 |
| HS 284440Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | +13.3% | $685.2M | 1 |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | +9.5% | $10.9B | 12 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +3.8% | $4.4B | 5 |
| HS 330300Perfumes and toilet waters | +1.1% | $7.3B | 7 |
| HS 381121Lubricating oil additives: containing petroleum oils or oils obtained from bituminous minerals | -3.8% | $362.9M | 1 |
| HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | -6.8% | $433.2M | 1 |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | -6.9% | $389.2M | 1 |
Diversification opportunities
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 330499
HS 300490
HS 330300
HS 382499
HS 382200
HS 300212
HS 330210
HS 282200
Frequently asked questions
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.